The European Medicines Agency has received some fresh requests to investigate former head Thomas Lonngren, who is now an industry consultant, for potential conflicts of interest committed before he left the agency late last year. Although the EMA has already consented to Lonngren's role as a consultant to drug companies, advocacy groups believe he bent some ethics rules when he arranged for the position while still working for the agency. They want the agency to take another look into the matter, Pharmalot reported. Article